Showing results (1541-1550 of 1,560) with videos related to

Sort By:
Pageof 156
Crystal Growth & Design|January 12, 2026
BEST-CSP Benchmark Study of Polymorphs I and II of Sulfamerazine and the Perils of Polytype PolymorphsWilliam P Wood, Mihails Arhangelskis, Erika Bartůňková, et al.
BMJ Open|March 27, 2023
Immune and metabolic markers for identifying and investigating severe Coronavirus disease and Sepsis in children and young people (pSeP/COVID ChYP study): protocol for a prospective cohort studySivakumar Oruganti, Patrícia R S Rodrigues, Daniel White, et al.
Emerging Infectious Diseases|July 25, 2023
Rapid Epidemic Expansion of Chikungunya Virus East/Central/South African Lineage, ParaguayMarta Giovanetti, Cynthia Vazquez, Mauricio Lima, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2025
Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United StatesPuja Nambiar, Tao Liang, Nazzarena Labo, et al.
Arquivos De Neuro-Psiquiatria|January 19, 2017
No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° SouthYara Dadalti Fragoso, Tarso Adoni, Soniza Vieira Alves-Leon, et al.
British Journal of Pharmacology|February 16, 2026
Chikungunya virus-induced persistent allodynia is accompanied by joint microenvironmental changes and involves cartilage degradation and TRPA1 activationLiziane C M da Silva, Andressa C Dos Santos Maia, Nágila C F de Sousa, et al.
Journal of the American Heart Association|March 13, 2026
Sympathetic Neural Overactivation, Vascular Dysfunction, and Exercise Intolerance in Long-Term Survivors of Breast Cancer Treated With Doxorubicin and Trastuzumab-Based ChemotherapyJoão E Izaias, Artur O Sales, Bruna E Ono, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 14, 2023
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patientsN B Amaral, T S Rodrigues, M C Giannini, et al.
RMD Open|February 5, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trialMaria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, et al.
Frontiers in Immunology|July 18, 2022
Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus AlumJúlio Souza Dos-Santos, Luan Firmino-Cruz, Alessandra Marcia da Fonseca-Martins, et al.
Pageof 156